A stroke causes brain damage. When this damage occurs in areas that control functions such as memory, problem-solving, concentration, and communication, it can cause confusion. Confusion is a ...

Their analysis identified magnetic resonance imaging (MRI) segmentation and enlarged perivascular spaces in the Basal ganglia as recent research ... as a mediator of poor outcomes following ischemic ...

The analysis, which includes two studies looking into the benefits of revascularization in patients with ischemic LV dysfunction ... endpoint of STICH3C is a composite of all-cause mortality, stroke, ...

In the US, the rate of ischemic stroke among adults aged 20 to 44 surged from 17 per 100,000 adults in 1993 to 28 per 100,000 in 2015. The risk of stroke death among young adults is also on the rise.

Another type of stroke is known as a transient ischemic attack (TIA) or ministroke. This is when the brain's blood supply is briefly blocked. It can cause temporary damage and raises the risk of ...

The U.S. Food and Drug Administration has approved TNKase (tenecteplase), a thrombolytic or clot-dissolving agent, for the treatment of acute ischemic stroke in adults. TNKase is delivered as a ...

Mini stroke, also known as a transient ischemic attack (TIA) is a short period of symptoms that are similar to that of a stroke. It is like a temporary stroke wherein there's a temporary lack of ...

The objectives are as follows: To assess the benefits and harms of intensive systolic blood pressure management (target less than 160 mmHg) versus conventional management (target less than 180 mmHg) ...

The FDA has approved TNKase, a tissue plasminogen, clot-dissolving agent, to treat acute ischemic stroke in adults, according to the manufacturer. Genentech said in a press release that TNKase ...

The AcT (Alteplase compared to Tenecteplase) trial compared TNKase to Activase in treating patients with acute ischemic stroke that presented with a disabling neurological deficit. This ...